Share Price:

APNASPENAspen Pharmacare Hldgs22071428 (1.98%)

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform to be released on 4 March 2024.

CNN Live – Aspen’s US$700m investment in equitable vaccine access for Africa

CNN's Julia Chatterley spoke to Stephen Saad about Aspen's US$700 m investment in vaccine supplies for Africa

“Over 90% of our vaccines are imported. A high majority from #India. When India cut off all exports, #Africa was left without vaccines.” Stephen Saad, CEO @aspenpharma discusses their recent $700M investment & ensuring future Africa supplies.

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.